The device returns a concentrated blood product consisting of all cell species plus a varying amount of plasma. The Hemosep device is capable of high concentration rates. We have produced PCVs of over 75%, but this takes more time. The selected PCV reflects that of competitive devices and meets the level commonly required by clinicians.
Posted in: Hemosep